1.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Global Growth Factors ( Blood And Tissue ) IndustryPublished on January 2011 Report SummaryThis report analyzes the worldwide markets for Growth Factors (Blood And Tissue) in US$ Million by the following growth factor types:Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins), and Tissue Growth Factors. Thereport provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World.Annual estimates and forecasts areprovided for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets.The report profiles 88companies including many key and niche players such as Alseres Pharmaceuticals, Inc., Amgen, Inc., Bayer HealthCarePharmaceuticals Inc., BioMimetic Therapeutics, Inc., Biopharm GmbH, Bolder Biotechnology, Inc., Ceregene Inc., FibroGen Inc.,FzioMed Inc., Novo Nordisk A/S, Reliance GeneMedix Plc, Insmed Inc., Johnson & Johnson, Janssen-Ortho, Inc., Lonza Group,Maxygen, Inc., Merck Serono International S.A., NsGene A/S, PeproTech, Inc., Rentschler Biotechnologie GmbH, F. Hoffmann-LaRoche Ltd., Chugai Pharmaceutical Co. Ltd., Genentech, Inc., Shantha Biotechnics, Scil Proteins GmbH, and Wockhardt Ltd. Marketdata and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research andreported select online sources. Table of ContentGROWTH FACTORS (BLOOD AND TISSUE)MCP-1217A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS 1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1 Study Reliability and Reporting Limitations 1 Disclaimers 2 Data Interpretation & Reporting Level 2 Quantitative Techniques & Analytics 3 Product Definitions and Scope of Study 3 Blood Growth Factors 4 Erythropoietins 4 Colony Stimulating Factors 4 Interferons 4 Interleukins 4 Tissue Growth Factors 4 2. INTRODUCTION 6 Growth Factors: A Preface 6 Current and Future Analysis 6Global Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 1/15

2.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Analysis By Region 6 US - The Single Largest Market 6 Growth Factors Market in Europe 6 Market for Growth Factors in Rest of World 6 Table 1: World Market for Growth Factors (2007-2015): Geographic Regions Ranked by CAGR - US, Japan, Rest of World, and Europe (includes corresponding Graph/Chart) 7 Analysis by Growth Factor Type 7 Growth Factors: Their Role and Related Applications 8 Growth Factors: Adding a New Dimension 8 Growth Factors: Classification Based on Activity 8 Recent Trends & Developments 8 Recombinant Human Erythropoietin: Gradually Gaining Dominance 9 Leading EPO Drugs Worldwide 9 Market Comparison of Erythropoietin-Based Drugs in America and European Union 9 Patent Expiries of Major Biopharmaceutical Drugs: 2001-2007 10 Patent Expiries of Select Biopharmaceuticals in Europe andUnited States: 2010 and Beyond 10 3. MARKET DYNAMICS 11 Major Companies Impacted by Patent Expiries 11 Patent Expiries Fuel Competition and Sales 11 Side Effects - Still a Concern 11 CDER- A Regulatory Review Authority for Growth Factors 11 Innovative Delivery System Shows Potential for Accelerating Use of Growth Factors 12 Cytokines- Vital Growth Propellers for the Future of New Drugs 12 Brain Derived Neurotrophic Factor (BDNF) Finds Increased Application 12 Age-Related Diseases - Their Influence on Effective Therapies 12 Mimetic Growth Factors - Exhibiting Promising Potential 13 India - At the Center Stage 13 4. INDUSTRY ISSUES 14 Development of Cost Effective Methods - Need of the Hour 14 Influence of Neurotrophic Factors on Brain Cell Development 14 Combination of Interferons and Ribavirin Develops More Anemia Cases 14 5. GROWTH FACTORS - AN OVERVIEW 15 Blood Growth Factors 15 Erythropoietins 15 Types of Erythropoietins 16 Epoetin 16 Darbepoetin 16 Aranesp® 16 Aranesp Vs. Other EPOs 16 Recombinant Human EPO (rHuEPO) 16 Table 2: World Market for Erythropoietins (2007-2015): Geographic Regions Ranked by CAGR -Rest of World, Japan, USGlobal Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 2/15

3.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! and Europe (includes corresponding Graph/Chart) 17 Colony Stimulating Factors 17 Granulocyte-Colony Stimulating Factor 17 Granulocyte Macrophage-Colony Stimulating Factor 18 Other Colony Stimulating Factors 18 Macrophage Colony Stimulating Factor (M-CSF) 18 Key Functions of M-CSF 18 Side-Effects of Colony-Stimulating Factors 18 Table 3: World Market for Colony Stimulating Factors (2007-2015): Geographic Regions Ranked by CAGR - Europe, US, Japan and Rest of World (includes corresponding Graph/Chart) 19 Interferons 19 Types of Interferons 19 Interferon-gamma 20 1a and 1b: Two Key Biochemical Forms of Interferon-ß 20 PEG-Intron 20 Types of Interferons 20 Table 4: World Market for Interferons as Blood Growth Factors (2007-2015): Geographic Regions Ranked by CAGR - US, Europe, Japan, and Rest of World (includes corresponding Graph/Chart) 21 Interleukins 21 Types of Interleukins 21 Table 5: World Market for Interleukins as Blood Growth Factors (2007-2015): Geographic Regions Ranked by CAGR - Europe, Rest of World, Japan and US (includes corresponding Graph/Chart) 22 Tissue Growth Factors 23 Wound Healing Growth Factors 23 Neurotrophic Growth Factors 23 Nerve Growth Factor 23 Vascular Endothelial Growth Factor (VEGF) 23 Fibroblast Growth Factor (FGF) 24 Insulin-Like Growth Factor-I (IGF-I) 24 Insulin-Like Growth Factor-II (IGF-II) 24 Tissue Growth Factors: Classification Based on Key Source and Principal Activity 24 Platelet - Derived Growth Factors in Wound Healing 24 Thrombopoietin (TPO) 25 Table 6: World Market for Tissue Growth Factors (2007-2015): Geographic Regions Ranked by CAGR - US, Europe, Japan, and Rest of World (includes corresponding Graph/Chart) 25 Growth Factors: Their Mode of Action in Tissue Repair 25 Angiogenesis: Their Role in Wound Healing 26 Angiogenesis As an Alternative for Cardiac Stents 26 Applications of Growth Factors 26Global Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 3/15

4.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Growth Factors: Suppliers and Applications 27 Growth Factors: Site/Course of Action and Applications 27 6. RESEARCH AND DEVELOPMENT HIGHLIGHTS A RECENT PAST PERSPECTIVE 28 Maxygen Updates on Factor VII Program 28 Evaluation of Extended Dosing Schedule of PROCRIT® 28 PROCRIT® - A Better Option 28 Nerve Growth Factor Shows Promising Potential Against Diabetes 28 Cytokines and GM-CSF Found to be Closely Interlinked 29 GM-CSF Enhances Rate of Survival in Neonates 29 rG-CSF Well Tolerated in Pneumonia and Severe Sepsis Patients 30 rG-CSF- Their Influence on Preterm Infants with Sepsis 30 Serum Macrophage Colony Stimulating Growth Factors Associated with Thrombocyte and Monocyte 30 Src Pathway Inactivation in Kit Impairs Blood Cell Growth and Proliferation 30 Cole Eye Institute Offers TIMP-3 Mechanism for Preventing Abnormal Growth of Blood Vessels 31 Effect of Brain Derived Neurotrophic Factor on Retinal Cells 31 Orcel Exhibits High Growth Factor for Wound Healing and Cardiovascular Applications 32 Drug Combination of Macrophage Colony Stimulating Factor Shows Successful Tolerance Levels 32 Neotrofin Triggers Neurotrophic Factors 32 G-CSF Shows Capability for Promoting Neutrophil Production 33 Insulin-like Growth Factor-1 (IGF) Gene Transfer Accelerates Wound Healing Process 33 Hepatocyte Growth Factors - Exhibiting Dual Role 34 Cortex Pharmaceuticals Ampakines® Promotes Expression of Neurotrophin 34 Granulocyte Colony Stimulating Factor Finds Application in Treating Neonates 34 Cerebrolysin Promotes Cognition 34 7. BREAKTHROUGHS - A RECENT PAST REVIEW 35 Novel Set of Human Cytokines Unveiled 35 IGFBP-3 and its Potential to Ward Off Gastric Cancer 35 Bone Morphogenic Proteins Show Potential for Musculoskeletal Regeneration 35 Growth Factors - Their Role in Preventing Heart Stroke 35 Growth Factor Proteins Show Promising Results for Treating Cancer 35 Neurotrophic Growth Factor - Primarily Responsible for Loss of Vision 36 Redox-Active Grape Seed Exhibits Favorable Properties for Dermal Wound Healing 36 Role of Brain-Derived Neurotrophic Factor on Memory 36 Nerve Growth Factor Found to Enhance Barium Current and Insulin Secretion 36Global Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 4/15

5.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Lipid Peroxidation May be Associated with Wound Healing 37 Genentech Inc Unveils Molecule for Stimulating Growth of Blood Vessels 37 Connective Tissue Growth Factor Found to Promote Lung Fibroblast 37 Influence of Insulin-Like Growth Factor on Growth 38 Regeneron Discovers Angiopoietins Targeted at Blood Vessel Growth and Repair 38 Environment and Insulin-Like Growth Factors Stimulate Risk of Cancer 38 Cocktail of Neurotrophic Factors Promotes Regeneration of Torn Nerves 38 Growth Factors Administration to Stimulate Tissue Repair 39 Cytokine - Their Role in Combating Hepatitis C Virus 39 Axokine® Yields Favorable Results Against Obesity 39 Cell Genesys Unveils GDNF Gene Therapy Targeted Against Parkinsons Disease 39 8. PRODUCT LAUNCHES 40 Sandoz Unveils Zarzio 40 Wockhardt Launches Three Biotechnology Products 40 Extavia® Receives Approval from European Commission 40 Amgen Bags EC Approval on Use of Aranesp(R) in Paediatric Patients 41 Hospira Receives EC Approval on Retacrit 41 Tercica Receives FDA Approval For Increlex 41 Ventria Bioscience Introduces Lacromin 41 Dragon Pharmaceuticals Bags Market Approval from Chinese SDA 41 DPI Receives Approvals for Erythropoietin in Three New Markets 42 Wockhardt Introduces Wepox Recombinant Erythropoietin Drug 42 Shanta Biotechnics Unveils Shanferon 42 SkinMedica Unveils TNS Recovery Complex Gel 42 CellGenix Unveils Cytokines for Cell Applications 42 Cel-Sci Corporation Develops Multikine 43 Wockhardt Limited Unveils EPOX 43 9. RECENT INDUSTRY ACTIVITY 44 Soluble Systems Collaborates with LifeNet Healths Subsidiary to Introduce TheraSkin 44 GlaxoSmithKline and JCR Pharmaceuticals Enters into Partnership 44 Kaken Pharmaceutical Enters into Licensing Agreement with Olympus Corporation 44 Biovitrum and Amgen Sign Agreement 45 Merck Establishes Production Unit 45 Eli Lilly and Company Acquires ImClone Systems 45 GeneMedix Changes Name to Reliance GeneMedix 46 FDA Approves Label Expansion for VIDAZA 46 Pfizer Inks Exclusive Global Licensing Agreement with Scil Technology 46Global Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 5/15

6.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! ZGEN Initiates Ph II Trial of Interleukin 21 47 FzioMed Bags Health Canada Approval on Oxiplex® 47 NsGene A/S Implants Encapsulated Cell in Patients 47 10. INDUSTRY ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 48 Reliance Life Sciences Takes Over Genemedix 48 Fraunhofer Institute Introduces First Interferon Beta 1a to Treat Multiple Sclerosis 48 Shanghai Wanxing Inks Export Deal for Recombinant Human Interferon 48 Hemispherx Enters into Distribution Agreement with Armada 49 Bayer Establishes US Pharmaceuticals Subsidiary 49 Merck Inks Agreement with Bristol-Myers Squibb and ImClone 49 CoGenesys Signs Global Licensing Agreement with Vegenics 49 InterMune Inks New Supply Deal with Boehringer Ingelheim 50 Boston Life Sciences Adopts New Name of Alseres Pharmaceuticals 50 Cambrex Divests Bioproducts and Biopharma Subsidiaries 50 Dragon Divests EPO Business 51 Caregene and Genzyme Forms Partnership to Develop Cere-120 51 NsGene to Undertake Phase Ib Clinical Trial of NsG0202 51 Roche Receives European approval for NeoRecormon 51 Bolder Receives Two U.S. Patents for Hematopoietic Factors 52 RLS to Initiate Clinical Trials of Erythropoietin 52 InterMune Drops Phase III trial of Interferon 52 Chugai to Conduct Additional Trial on Epogin® 52 Merck KGaA Acquires Serono Labs 52 CytoPharm Acquires Low-Dose Interferon License from Amarillo Biosciences 53 Hospira Signs Agreements with STADA and BIOCEUTICALS for Erythropoietin 53 Biocon Bags GEAC Approval to Conduct Clinical Trial of Granulocyte Colony Stimulating Factor 53 SII to Conduct Clinical Trials of Rdna Products 53 Claris to Construct Production Facility for EOP 54 Mayne and Pliva to End Collaboration on Erythropoietin Development 54 GeneMedix Collaborates with CJ Corp. 54 FzioMed and USC Enter into Licensing Agreement for Oligopeptides 54 AnGes MG Enters Into An Agreement with Vical 55 Corautus and BIA Sign Agreement for VEGF-2 plasmid DNA 55 Dragon Pharmaceuticals Acquires Oriental Wave 55 Insmed Enters into Exclusive Agreement with UCSF for IGF-1 Series 55 Amrad and Ludwig Institute Jointly Focus on the Development of VEGF-B 55 GeneMedix Restructures Business 56 pSivida Limited Collaborates with Ian Wark Research Institute 56 Amgen Acquires Tularik 56 BMPI Signs up Luitpold Pharmaceuticals for FDA Approved GEM 21S 56Global Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 6/15

7.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Chugai and Roche Expand Drug Research Synergies 56 Dragon Pharmaceuticals to Construct New Production Facility 57 FibroGen Signs Contract with Yamanouchi for Licensing EPO Small Molecule 57 Insmed and Tzamal Pharma Sign Agreement for Promoting SomatoKine 57 Maxygen and Rentschler Enter into a Contract for G-CSF 57 Maxygen Signs Agreement with Biovitrum for Manufacturing Beta Interferon 57 Dragon Pharmaceuticals Signs Agreement with Zhongkai 58 Dragon Pharmaceuticals Enters into Definitive Agreement with Oriental Wave 58 Zymogenetics Bags US FDA Clearance 58 Ceregene Bags Patent 58 AME Enters into Third Collaboration with Eli Lilly and Company 58 ViaCell Enters into Licensing Agreement and Collaboration with Amgen 59 Ceregene Enters into Licensing Agreement with Genentech 59 BIOPHARM GmbH Enters into Licensing Contract with DePuy 59 Maxygen Enters into a Deal with Roche Holding 59 GeneMedix Signs Agreement with SkyePharma 60 Neurotech Enters into Licensing Agreement with Amgen 60 Ceregene Enters into a Licensing Agreement with Washington University 60 NeoTherapeutics Receives US Patent for Stimulating Neuritogenesis 60 BioSET Bags Global Exclusive License for Novel Growth Factor Technology 60 ViaCell Acquires Cerebrotec 60 Fibrogen Collaborates with Sankyo 61 Prescient NeuroPharma Collaborates with SRIB 61 Dragon Pharmaceuticals Signs Agreement with Renapharm AB and Transworld 61 Baxter Bags Exclusive Worldwide Rights for Epoetin Omega 61 Ortec International Bags FDA PMA for OrCel 61 GeneMedix Bags Chinese SDA Approval 62 NsGene Collaborates with ARIAD Pharmaceuticals 62 Regeneron Enters into Agreement with Emisphere Technologies 62 NsGene A/S Signs Agreement with Biogen Inc 62 NTB Enters into BioInformatics Outsourcing Agreement with HSC 6311. FOCUS ON SELECT GLOBAL PLAYERS 64 Alseres Pharmaceuticals, Inc. (USA) 64 Amgen, Inc. (USA) 64 Bayer HealthCare Pharmaceuticals Inc. (USA) 64 BioMimetic Therapeutics, Inc. (USA) 65 Biopharm GmbH (Germany) 65 Bolder Biotechnology, Inc. (USA) 65 Ceregene, Inc. (USA) 65 FibroGen, Inc. (USA) 66Global Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 7/15

8.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! FzioMed, Inc. (USA) 66 Novo Nordisk A/S (Denmark) 66 Reliance GeneMedix Plc. (UK) 66 Insmed, Inc. (USA) 67 Johnson & Johnson (USA) 67 Janssen-Ortho, Inc. (Canada) 68 Lonza Group (Switzerland) 68 Maxygen, Inc. (USA) 68 Merck Serono International S.A. (Switzerland) 69 NsGene A/S (Denmark) 69 PeproTech, Inc. (USA) 69 Rentschler Biotechnologie GmbH (Germany) 69 F. Hoffmann-La Roche Ltd (Switzerland) 70 Chugai Pharmaceutical Co. Ltd. (Japan) 70 Genentech, Inc. (USA) 70 Shantha Biotechnics (India) 71 Scil Proteins GmbH (Germany) 71 Wockhardt Ltd. (India) 71 12. GLOBAL MARKET PERSPECTIVE 72 Table 7: World Recent Past, Current & Future Analysis for Growth Factors (Blood and Tissue) by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 72 Table 8: World Historic Review for Growth Factors (Blood and Tissue) by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 73 Table 9: World 11-Year Perspective for Growth Factors (Blood and Tissue) by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 74 Table 10: World Recent Past, Current & Future Analysis for Blood Growth Factors by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 75 Table 11: World Historic Review for Blood Growth Factors by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 76Global Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 8/15

9.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Table 12: World 11-Year Perspective for Blood Growth Factors by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 77 Table 13: World Recent Past, Current & Future Analysis for Blood Growth Factors by Type - Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 78 Table 14: World Historic Review for Blood Growth Factors by Type - Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 79 Table 15: World 11-Year Perspective for Blood Growth Factors by Type - Percentage Breakdown of Value Sales for Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 80 Table 16: World Recent Past, Current & Future Analysis for Erythropoietins by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 81 Table 17: World Historic Review for Erythropoietins by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 82 Table 18: World 11-Year Perspective for Erythropoietins by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 83 Table 19: World Recent Past, Current & Future Analysis for Colony Stimulating Factors by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 84 Table 20: World Historic Review for Colony Stimulating FactorsGlobal Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 9/15

10.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 85 Table 21: World 11-Year Perspective for Colony Stimulating Factors by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 86 Table 22: World Recent Past, Current & Future Analysis for Interferons as Blood Growth Factors by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 87 Table 23: World Historic Review for Interferons as Blood Growth Factors by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 88 Table 24: World 11-Year Perspective for Interferons as Blood Growth Factors by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 89 Table 25: World Recent Past, Current & Future Analysis for Interleukins as Blood Growth Factors by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 90 Table 26: World Historic Review for Interleukins as Blood Growth Factors by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 91 Table 27: World 11-Year Perspective for Interleukins as Blood Growth Factors by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 92 Table 28: World Recent Past, Current & Future Analysis for Tissue Growth Factors by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015Global Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 10/15

11.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! (includes corresponding Graph/Chart) 93 Table 29: World Historic Review for Tissue Growth Factors by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 94 Table 30: World 11-Year Perspective for Tissue Growth Factors by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 95 13. THE UNITED STATES 96 A.Market Analysis 96 Current and Future Analysis 96 Leading EPO Drugs in the US 96 B.Market Analytics 97 Table 31: US Recent Past, Current & Future Analysis for Growth Factors by Type - Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins) and Tissue Growth Factors Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 97 Table 32: US Historic Review for Growth Factors by Type - Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins) and Tissue Growth Factors Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 98 Table 33: US 11-Year Perspective for Growth Factors by Type - Percentage Breakdown of Value Sales for Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins) and Tissue Growth Factors Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 99 14. JAPAN 100 A.Market Analysis 100 Current and Future Analysis 100 Erythropoietin Market 100 Leading EPO Drugs in Japan 100 Market Scenario for Biotech Products 100 Biotech Market Backed by Public Assistance 100 B.Market Analytics 101 Table 34: Japanese Recent Past, Current & Future AnalysisGlobal Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 11/15

12.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! for Growth Factors by Type - Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins) and Tissue Growth Factors Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 101 Table 35: Japanese Historic Review for Growth Factors by Type - Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins) and Tissue Growth Factors Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 102 Table 36: Japanese 11-Year Perspective for Growth Factors by Type - Percentage Breakdown of Value Sales for Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins) and Tissue Growth Factors Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 103 15. EUROPE 104 A.Market Analysis 104 Current and Future Analysis 104 Erythropoietin Market Scenario in the Recent Past 104 Leading EPO Drugs in Europe 104 B.Market Analytics 105 Table 37: European Recent Past, Current & Future Analysis for Growth Factors by Type - Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins) and Tissue Growth Factors Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 105 Table 38: European Historic Review for Growth Factors by Type - Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins) and Tissue Growth Factors Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 106 Table 39: European 11-Year Perspective for Growth Factors by Type - Percentage Breakdown of Value Sales for Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins) and Tissue Growth Factors Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 107 16. REST OF WORLD 108Global Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 12/15

13.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! A.Market Analysis 108 Current and Future Analysis 108 An Overview of Indian Market 108 Erythropoietin 108 G-CSF Market 109 Interferon 109 B.Market Analytics 110 Table 40: Rest of World Recent Past, Current & Future Analysis for Growth Factors by Type - Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins) and Tissue Growth Factors Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart) 110 Table 41: Rest of World Historic Review for Growth Factors by Type - Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins) and Tissue Growth Factors Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart) 111 Table 42: Rest of World 11-Year Perspective for Growth Factors by Type - Percentage Breakdown of Value Sales for Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons and Interleukins) and Tissue Growth Factors Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart) 112COMPETITIVE LANDSCAPE Total Companies Profiled: 88 (including Divisions/Subsidiaries - 100) ------------------------------------------ Region/Country Players ------------------------------------------ The United States 54 Canada 3 Japan 5 Europe 21 Germany 11 The United Kingdom 2 Rest of Europe 8 Asia-Pacific (Excluding Japan) 14 Middle-East 3 ------------------------------------------Global Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 13/15

14.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Global Growth Factors ( Blood And Tissue ) Industry Product Formats Please select the product formats and the quantity you require. 1 User License--USD 4 500.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________Global Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 14/15

15.
Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature: Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93Global Growth Factors ( Blood And Tissue ) Industry (From Slideshare) Page 15/15